Russia’s Biological Weapons Legacy: What Survived the Soviet Programme?

Russia denies developing prohibited biological weapons, describing its work as protection against dangerous infections. The United States, by contrast, maintains that the Soviet programme was not fully dismantled and that its infrastructure and expertise continued to evolve. A recent investigation into a restricted facility on Lisy Island has added names, locations, and documented institutional links to a story stretching back decades.

There is no direct public evidence that biological weapons are being produced on the island. But the history of the Soviet programme, US intelligence assessments and the limited information available about Russia’s military biological institutions explain why the question remains relevant.

A death at an anti-plague institute

On 2 October 2026, Darya Shipilova, a 28-year-old employee of the Irkutsk Anti-Plague Research Institute of Siberia and the Far East, died after developing severe pneumonia of unknown origin.

Because the institute works with particularly dangerous pathogens, the circumstances prompted speculation about possible plague infection and a laboratory accident. Russian authorities introduced precautionary measures, placing around 200 people who had been in contact with Shipilova under observation.

On 8 October, Russian officials said checks had been completed. According to their account, nearly 5,000 laboratory tests had found no dangerous pathogens among those monitored. The authorities attributed Shipilova’s death to pneumonia of unknown origin, not to a confirmed case of plague.

The World Health Organization requested further information from Russia. Reuters reported that questions about the circumstances of the death remained unresolved.

The case does not establish that plague escaped from the institute or that an outbreak was concealed. No plague cases were confirmed among Shipilova’s contacts. Yet the lack of a clear public explanation has renewed scrutiny of Russia’s work with dangerous pathogens.

To understand why such incidents attract particular attention, it is worth revisiting an earlier episode in which the Soviet authorities concealed a biological accident for years.

Sverdlovsk, 1979: a biological accident denied

In April and May 1979, a major anthrax outbreak struck the Soviet city of Sverdlovsk, now Yekaterinburg. The official explanation blamed contaminated meat. But the distribution of cases and medical evidence pointed towards a different source.

Many victims lived or worked in an area extending south from a military complex. Some developed pulmonary anthrax, which occurs when people inhale Bacillus anthracis spores.

By March 1980, a US intelligence assessment had linked the outbreak to an accident at a military facility suspected of working with biological agents. Washington’s public and diplomatic position was more cautious, however, and not every aspect of the incident or its implications had been conclusively established at the time.

In 1992, Russian President Boris Yeltsin acknowledged the connection between the tragedy and Soviet military biological research. A study published in Science in 1994 compared epidemiological records, the location of victims, and wind direction. Its authors concluded that the outbreak resulted from an airborne release of anthrax spores from a military microbiology facility.

Sverdlovsk became one of the clearest examples of a state concealing a dangerous biological incident while maintaining an official account that later scientific findings contradicted.

It does not prove that every Russian laboratory today follows Soviet practices. It does, however, provide essential context for assessing official statements about biological safety.

From the Soviet programme to modern Russia

The Soviet offensive biological weapons programme was extensive. It involved military institutions, research and production facilities, and organisations operating under civilian cover, including the Biopreparat system. Soviet programmes worked with pathogens including anthrax, plague and smallpox.

After the Soviet Union collapsed, Russia inherited parts of this infrastructure, along with personnel and scientific expertise. In 1992, Yeltsin announced the termination of the illegal biological weapons programme. The US government maintains that the dismantlement was never completed.

In its 2024 arms control compliance report, the US State Department stated that the Soviet programme had been “absorbed, not dismantled” by the Russian Federation and had continued to evolve.

The report also argued that Russia had not provided sufficient evidence that all prohibited activities had ceased or that it had fulfilled its obligations under the Biological Weapons Convention. Particular attention was paid to the modernisation of Soviet-era military biological infrastructure, including the Ministry of Defence’s 48th Central Scientific Research Institute.

These are assessments by the US government, not findings from an independent international inspection. Much of the underlying intelligence remains classified. The report therefore does not establish that every facility with a Soviet military history is currently producing biological weapons.

It does, however, set out Washington’s central concern: Russia retained an extensive scientific and institutional legacy, while the full fate of the former programme remains disputed.

A restricted island and the military biology connection

In September 2026, Radio Free Europe/Radio Liberty’s investigative project Systema published an investigation into the Centre for Experimental Physiology on Lisy Island in Russia’s Tver region. The journalists examined the facility’s history, management, public registration records and satellite imagery.

According to the investigation, the new complex was built between 2021 and 2025 on an island with restricted access. Satellite images show a laboratory building, residential facilities and other infrastructure.

The investigation’s most significant findings concern the centre’s leadership. Its director, Vladimir Maksimov, previously headed a military virology organisation linked to the Defence Ministry’s 48th Central Scientific Research Institute. Journalists also identified connections to Russia’s military biological system in the background of the centre’s deputy head.

The 48th Institute has roots in the Soviet period and works in biological defence. The United States sanctioned it in 2020 and subsequently referred to the modernisation of its infrastructure in arms control compliance reports.

The Centre for Experimental Physiology, meanwhile, formally belongs to Russia’s Federal Medical-Biological Agency. Its official website provides little detail about its scientific work.

The investigation establishes the existence of a restricted scientific complex and identifies personnel links to military virology. It does not establish that the centre produces biological weapons, tests a particular weaponised virus or prepares pathogens for deployment. No direct evidence of such activity has been made public.

That distinction matters. A facility’s secrecy and its leadership’s professional background justify questions, but they are not proof of a specific prohibited programme.

Where legitimate research ends and weapons development begins

Debate about Russia’s biological capabilities often conflates civilian laboratories, disease surveillance and military research. Working with dangerous pathogens is not, in itself, evidence of weapons development.

Anti-plague institutes study plague because it persists in natural reservoirs and requires epidemiological monitoring. Scientific centres may work with viruses and bacteria to develop diagnostic tests, vaccines, treatments and protective equipment. Such research can be legitimate even when it involves highly dangerous infectious agents.

The situation is different when biological agents are developed, stockpiled or adapted for hostile use. That is what the Biological Weapons Convention prohibits.

The US intelligence community’s 2026 Annual Threat Assessment stated that Russia, China and North Korea likely retain the knowledge and capabilities needed to produce and use traditional biological pathogens and toxins. It also referred to continued Russian development of capabilities in chemical and biological warfare. The public assessment does not, however, provide a verified inventory of a current Russian biological arsenal or demonstrate the production of specific weaponised strains.

There is therefore insufficient public evidence to conclude that Russia is currently engineering a particular genetically modified virus or preparing a biological attack. The US assessment nevertheless indicates that Washington considers Russia’s retained military biological capabilities a serious concern.

Reports of unusual events, including the mass culling of livestock in Siberian regions in 2026, have also prompted speculation. But no established link between those culls and military biological laboratories has been demonstrated. Suspicion should not be presented as proof.

What is known – and what remains unproven

Open sources establish that the Soviet Union operated a large offensive biological weapons programme and that the 1979 Sverdlovsk outbreak was linked to a military biological facility. Russia inherited part of that programme’s infrastructure, and the United States assesses that it was not fully dismantled.

The Lisy Island investigation has identified institutional and personnel links between a new restricted centre and Russia’s military biological establishment. US government reports have also documented modernisation at the 48th Central Scientific Research Institute.

But there is no direct public evidence that the Centre for Experimental Physiology on Lisy Island produces biological weapons. Nor is there a verified public inventory of Russia’s current weaponised pathogens, stockpiles or orders for their use.

Shipilova’s death does not prove that plague escaped from the Irkutsk institute. The Siberian livestock culls have no established connection to military biological laboratories. These incidents raise questions, but they cannot substitute for evidence.

The concern lies in the combination of Soviet-era expertise, the modernisation of military institutions and the uncertainty surrounding their present activities. Russia’s biological weapons legacy has not disappeared from the public record. What remains unresolved is how much of that legacy survives in operational form.